MedPath

ATX-01

Generic Name
ATX-01
Drug Type
Biotech

Overview

ATX-01 is an antimiR, a chemically modified antisense oligonucleotide, designed to target microRNA 23b (miR-23b).

Background

ATX-01 is an antimiR, a chemically modified antisense oligonucleotide, designed to target microRNA 23b (miR-23b).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 1
Recruiting
Posted: 2024/03/08
Sponsor:
ARTHEx Biotech S.L.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath